Showing results (181-190 of 232) with videos related to
Sort By:
Pageof 24
Pancreas|December 17, 2014
Low frequency of KRAS mutation in pancreatic ductal adenocarcinomas in Korean patients and its prognostic valueMi Jung Kwon, Jang Yong Jeon, Hye-Rim Park, et al.Oncotarget|November 16, 2017
Programmed death ligand-1 and MET co-expression is a poor prognostic factor in gastric cancers after resectionMi Jung Kwon, Kab-Choong Kim, Eun Sook Nam, et al.Biomed Research International|May 22, 2018
Identification of Phosphohistone H3 Cutoff Values Corresponding to Original WHO Grades but Distinguishable in Well-Differentiated Gastrointestinal Neuroendocrine TumorsMin Jeong Kim, Mi Jung Kwon, Ho Suk Kang, et al.International Journal of Cancer|March 12, 2014
MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancerYu Jin Kim, Jong-Sun Choi, Jinwon Seo, et al.Journal of Personalized Medicine|May 27, 2023
Comparison of the Concordance of Allergic Diseases between Monozygotic and Dizygotic Twins: A Cross-Sectional Study Using KoGES HTS DataEun Jae Lee, Joo-Hee Kim, Hyo Geun Choi, et al.The Journal of Pathology. Clinical Research|February 23, 2026
Cancer-associated fibroblasts are associated with CD8+ T cell depletion and poor prognosis in colorectal adenocarcinoma: a multi-omics and machine learning analysisMyungsun Shim, One-Zoong Kim, Byoung Kwan Son, et al.Indian Journal of Surgical Oncology|May 17, 2021
Negative Prognostic Implication of TERT Promoter Mutations in Human Papillomavirus-Negative Tonsillar Squamous Cell Carcinoma Under the New 8th AJCC Staging SystemHyunchul Kim, Mi Jung Kwon, Bumjung Park, et al.Pathology, Research and Practice|February 19, 2017
Concurrent MET copy number gain and KRAS mutation is a poor prognostic factor in pancreatobiliary subtype ampullary cancersMi Jung Kwon, Jeong Won Kim, Jang Yong Jeon, et al.Journal of Personalized Medicine|July 27, 2022
Changes in the Incidence Rates of Gastrointestinal Diseases Due to the COVID-19 Pandemic in South Korea: A Long-Term PerspectiveHyo Geun Choi, Ho Suk Kang, Hyun Lim, et al.Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Possible Association between the Use of Proton Pump Inhibitors and H2 Receptor Antagonists, and Esophageal Cancer: A Nested Case-Control Study Using a Korean National Health Screening CohortHyo Geun Choi, Hong Kyu Lee, Ho Suk Kang, et al.Pageof 24